Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid × pegfilgrastim × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 6 Breast Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma 4 Rhabdomyosarcoma 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Burkitt Lymphoma 3 Triple Negative Breast Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Pain 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Multiple Myeloma 1 Medulloblastoma 1

Interventions

fludarabine 6 Whole-Body Irradiation 6 Cyclophosphamide 6 fludarabine phosphate 4 Tacrolimus 4 Peripheral Blood Stem Cell Transplantation 4 Mycophenolic Acid 4 Busulfan 4 venetoclax 3 Azacitidine 3 gilteritinib 2 asciminib 2 aldesleukin 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Interleukin-2 2 Cytarabine 2 Bone Marrow Transplantation 2 spartalizumab 1 sabatolimab 1 ponatinib 1 nilotinib 1 nicotinamide-beta-riboside 1 methanesulfonic acid 1 interferon gamma-1b 1 enasidenib 1 blinatumomab 1 Thiotepa 1 Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡